The Lancet Respiratory Medicine in conversation with

Anne-Marie Dingemans; Isabelle Opiz; Corinne Faivre-Finn on a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability

Thu, 26 Mar 2026 00:00:00 +0000

Anne-Marie Dingemans, Isabelle Opiz, and Corinne Faivre-Finn talk about their multidisciplinary efforts to develop a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability.

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00051-2/fulltext

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Anne Holland and Christine McDonald

Mon, 02 Mar 2026 23:00:00 +0000

Anne Holland and Christine McDonald join Diana Stanley to discuss ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis.

Click here to read the full article, Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): a randomised sham-controlled trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00005-6/fulltext

Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest

Mon, 22 Dec 2025 23:00:00 +0000

Marion Moseby-Knappe talks about a prospective, international, observational biomarker study, within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial, to compare four markers of brain injury for the prediction of functional outcome in patients after cardiac arrest using assays that can be analysed on clinically available equipment.

Click here to read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00363-7/fulltext

Sailesh Kotecha on Prematurity-associated lung disease

Thu, 27 Nov 2025 23:00:00 +0000

Prof Sailesh Kotecha joins Diana Stanley to discuss the series on reframing prematurity-associated lung disease as a continuum that begins before birth and evolves throughout life.

Cick here to read the full series:

Looking beyond bronchopulmonary dysplasia: prematurity-associated lung disease and its phenotypes
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00372-8/fulltext

Trajectories of prematurity-associated lung disease: lifelong lung health
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00371-6/fulltext

Management of prematurity-associated lung disease from infancy through to adulthood
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00369-8/fulltext

Neil Greening and Hnin Aung on Multidimensional prognostic risk stratification of COPD exacerbations

Tue, 25 Nov 2025 23:00:00 +0000

Dr Neil Greening and Dr Hnin Aung join Diana Stanley to discuss a new multidimensional prognostic risk stratification model for COPD exacerbations.

click here to read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00362-5/fulltext

Finn McQuaid and Matthew Saunders on Tuberculosis and Climate change

Thu, 30 Oct 2025 23:00:00 +0000

Dr Finn McQuaid and Dr Matthew Saunders join Arianna Colosio to discuss an analytical framework to describe potential causal relationships between climate change and tuberculosis.

Click here to read the full article

Toby Maher on ENV-101 in patients with idiopathic pulmonary fibrosis

Sun, 28 Sep 2025 09:00:00 +0000

Toby Maher joins us to discuss results of a randomised, double-blind, placebo-controlled, proof-of-concept trial of ENV-101, an oral inhibitor of the hedgehog signalling pathway, in patients with idiopathic pulmonary fibrosis.

Read the full article:

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00239-5/fulltext?dgcid=buzzsprout_icw_podcast_September_25_lanres

Guy Brusselle and Celeste Porsbjerg on State-of-the-art insights into prevention, development, and management of asthma

Sun, 28 Sep 2025 09:00:00 +0000

Professors Guy Brusselle and Celeste Porsbjerg join us to discuss their recent Series papers on asthma, which will be featured in a cross journal project with The Lancet, published to coincide with a Lancet journal session on asthma at ERS in Amsterdam.

The Series aims to provide an overview of recent research advances related to asthma; to provide new insights into the genetics, prevention and risk factors for asthma; review advances arising as a result of the use of monoclonal antibody therapeutics; and assess remission in adult patients. Late breaking research will also be included within the journal session and linked to the Series.

Read the full Series:

https://www.thelancet.com/series-do/asthma-2025?dgcid=buzzsprout_icw_podcast_asthma25_lanres

Joan Soriano on Global Epidemiology of Respiratory Disease

Thu, 17 Jul 2025 22:00:00 +0000

Diana Stanley, Deputy Editor at The Lancet Respiratory Medicine, is joined by Dr Joan Soriano to discuss a new series on the global epidemiology of respiratory disease, exploring the diagnostic challenges, global trends, and future directions for prevention.

Read the full Series:

https://www.thelancet.com/series-do/global-epidemiology-chronic-respiratory-disease?dgcid=buzzsprout_icw_podcast_lanrescrd25_lanres

Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q trial

Wed, 16 Jul 2025 22:00:00 +0000

Carole Mitnick & Lorenzo Guglielmetti join Ari Colosio, deputy editor of The Lancet Respiratory Medicine, to discuss the ENDTB-Q trial to evaluate the efficacy and safety of a drug regiment to treat TB in individuals with pre-extensively drug-resistant tuberculosis.

Read the full article:

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00194-8/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanres

Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)

Wed, 16 Jul 2025 22:00:00 +0000

This episode is in Italian. For the English version, please see the main feed.

Lorenzo Guglielmetti sul trial clinico ENDTB-Q per valutare l’efficacia e la sicurezza di un regime di farmaci per curare la tubercolosi in individui con tubercolosi pre-estesa farmaco-resistente.

Leggi l'articolo completo:

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00194-8/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanres

Laura Garriga-Grimau on bronchiectasis in children and young people

Wed, 02 Jul 2025 12:00:00 +0000

Deputy editor Ari Colosio speaks with Dr. Laura Garriga-Grimau of the Val d’Hebron Hospital, Autonomous University of Barcelona. Dr. Garriga-Grimau discusses the first multi-country cohort study to describe the clinical features and standards of care for children and young people with bronchiectasis, drawing on data from the International Pediatric Bronchiectasis Registry.

Together, they examine key findings on regional differences in diagnosis, co-morbidities, clinical severity, and treatment practices across eight countries. Dr. Garriga-Grimau highlights the significant burden of bronchiectasis on patients and health systems, as well as the urgent need for earlier diagnosis, harmonised international guidelines, and more equitable research and care.

Read the full article:

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00089-X/abstract?dgcid=buzzsprout_icw_podcast_July_25_lanres

Marcus J Schultz and Prashant Nasa on defining and subphenotyping ARDS

Wed, 04 Jun 2025 08:00:00 +0000

Bianca Brandon is joined by Professor Marcus Schultz and Dr Prashant Nasa to discuss their recent Position Paper reporting insights from an international Delphi expert panel on defining and subphenotyping ARDS. The findings underscore the need to refine the ARDS definition to better address heterogeneity of the condition and improve diagnostic precision, with use of subphenotyping where appropriate.

Read the full article:

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00115-8/fulltext?dgcid=buzzsprout_icw_podcast_Jun_25_lanres

Hjalmar Bouma on sepsis in patients who are immunocompromised

Tue, 20 May 2025 22:00:00 +0000

Bianca Brandon, Senior Editor at The Lancet Respiratory Medicine, is joined by Professor Hjalmar Bouma to discuss a new review on sepsis in immunocompromised patients, exploring the diagnostic challenges, complexities of immune status, and future directions for targeted therapies. The episode also analyses the increased vulnerability of specific patient groups, the importance of biomarker-driven personalised medicine, and the need for improved representation of immunosuppressed patients in clinical trials.

Read the full article:

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00124-9/fulltext?dgcid=buzzsprout_icw_podcast_May_25_lanres

Simon Wolf on pulmonary embolism in children and adolescents in the US during 2016 and 2019

Mon, 07 Apr 2025 08:00:00 +0000

Deputy Editor of The Lancet Respiratory Medicine Ari Colosio discusses the critical findings of a new epidemiological study on pulmonary embolism in children and adolescents with Simon Wolf from the University Hospital of Zurich.

This episode delves into the prevalence, risk factors, and clinical implications of this rare but serious condition, highlighting the need for increased awareness and further research.

Read the full article:

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00412-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres

Sandeep Sahay and Franck Rahaghi on future treatment paradigms in pulmonary arterial hypertension

Wed, 19 Feb 2025 23:00:00 +0000

Dr Sandeep Sahay and Professor Franck Rahaghi discuss their Personal View on future treatment paradigms in pulmonary arterial hypertension.

Read the full paper, Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients, here: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00425-9/fulltext

Sergio Harari sul trattamento della linfangioleiomiomatosi (LAM) (in Italian)

Fri, 25 Oct 2024 22:00:00 +0000

Il Professor Sergio Harari commenta i risultati di un trial clinico di fase 2 volto a valutare l’attivita’ e la sicurezza del farmaco nintedanib come trattamento in pazienti affetti da linfangioleiomiomatosi (LAM).

Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM)

Fri, 25 Oct 2024 22:00:00 +0000

Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM).

Robert Kullberg on empirical antibiotics for Sepsis

Fri, 11 Oct 2024 22:00:00 +0000

Dr Robert Kullberg joins us to discuss his Viewpoint on empiric antibiotic therapy for sepsis and the importance of reducing unnecessary use of anti-anaerobic antibiotics.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00257-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres

Heather Zar on early-life RSV disease and long-term respiratory health

Mon, 09 Sep 2024 08:00:00 +0000

Professor Heather Zar joins The Lancet Respiratory Medicine to discuss early-life RSV disease and long-term respiratory health. This topic will be covered in one of four Series papers in a cross-journal Series with The Lancet.

You can read the Series of papers at:
https://www.thelancet.com/series/respiratory-syncytial-virus?dgcid=buzzsprout_icw_podcast_generic

Margaux Mesle on lives saved by COVID-19 vaccination

Wed, 07 Aug 2024 22:00:00 +0000

Dr Margaux Mesle discusses estimates of lives directly saved by COVID-19 vaccination programs in the WHO European Region in the period from 2020 to 2023 and public health implications.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00179-6?dgcid=buzzsprout_icw_podcast_generic_lanres

James Hull on protecting the respiratory health of athletes

Thu, 25 Jul 2024 22:00:00 +0000

Professor James Hull joins us to discuss his recent Spotlight on protecting the respiratory health of athletes ahead of the Summer Olympics and Paralympics.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00183-8?dgcid=buzzsprout_icw_podcast_generic_lanres

Eric Lim on treatments for pleural mesothelioma

Fri, 10 May 2024 22:00:00 +0000

Professor Eric Lim discusses the outcomes after extended pleurectomy decortication plus chemotherapy versus chemotherapy alone for pleural mesothelioma.

Anne Chang on the burden of chronic respiratory diseases in Indigenous people

Wed, 24 Apr 2024 22:00:00 +0000

Dr Anne Chang discusses the burden of chronic respiratory diseases in Indigenous people.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00008-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres

Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC

Tue, 12 Mar 2024 23:00:00 +0000

Professor Daniel Steinfort and Professor Shankar Siva discuss the effect of systematic endoscopic mediastinal staging on radiotherapy field planning in patients with locally advanced non-small-cell lung cancer.

Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID

Tue, 16 Jan 2024 12:00:00 +0000

Prof Daniel Prieto-Alhambra, Dr Annika Jödicke, and Dr Martí Català discuss the effectiveness of COVID-19 vaccines to prevent Long COVID, estimated to affect up to 20% of those infected with SARS-CoV-2.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00414-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres

Sarah Gorst and Tim Nicholson on long COVID outcomes

Thu, 02 Nov 2023 23:00:00 +0000

Dr Tim Nicholson and Dr Sarah Gorst discuss the development of an international Delphi consensus study on a core outcome measurement set for long COVID and how it will be used to inform future research and clinical care.

Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19

Wed, 04 Oct 2023 10:00:00 +0000

Dr Betty Raman discusses multiorgan MRI findings in patients after hospitalisation with COVID-19.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00262-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres

Keith Chappell on a bivalent recombinant vaccine for COVID-19

Wed, 13 Sep 2023 22:00:00 +0000

Dr Keith Chappell discusses the bivalent recombinant vaccine for COVID-19 following the study by Dayan and colleagues, with focus on vaccine access, variants and boosters, tolerability and side effects, as well as hopes for future trials.

James Chalmers on bronchiectasis across Europe

Wed, 26 Apr 2023 11:00:00 +0000

Prof. James Chalmers discusses the characteristics of patients with bronchiectasis across Europe, the differences between countries, and possible differences in clinical outcomes, based on data from the EMBARC registry.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00093-0/fulltext?dgcid=buzzsprout_tlv_episode-notes_general_general

Richard Costello on management of uncontrolled asthma

Tue, 21 Mar 2023 23:00:00 +0000

Prof Richard Costello discusses the use of digital measurements of medication adherence and lung function to guide management of uncontrolled asthma.

Keiju Aokage on segmentectomy for ground-glass-dominant lung cancer

Mon, 06 Mar 2023 23:00:00 +0000

Dr Keiju Aokage discusses segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less.

Read the full article:
Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial

Carol Hodgson on post-discharge outcomes for ECMO patients

Thu, 09 Feb 2023 11:00:00 +0000

Carol Hodgson discusses recent advances in our understanding of in-hospital and post-discharge outcomes in critically ill patients who receive ECMO.

Read the full article:
Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES)

Emma Grainger on 10 years of The Lancet Respiratory Medicine

Thu, 22 Dec 2022 23:00:00 +0000

Emma Grainger, Editor-in-Chief of The Lancet Respiratory Medicine, discusses the January issue and plans to celebrate the 10-year anniversary of the journal.

Read the Editorial from the 10th anniversary issue:
Past learnings and new beginnings in the digital age

Vivienne Kahlmann and Catharina Moor on the TIRED study

Wed, 23 Nov 2022 17:00:00 +0000

Vivienne Kahlmann and Catharina Moor discuss a study looking at online mindfulness-based cognitive behaviour treatment to address fatigue associated with sarcoidosis.

Read the full article:
Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED)

Yves Lacasse on long-term oxygen therapy for COPD

Sun, 31 Jul 2022 23:00:00 +0000

Yves Lacasse joins The Lancet Respiratory Medicine to discuss a meta-analysis on the effectiveness of home oxygen use for patients with COPD.

Read the full article:
Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis

Rachael Evans on living with long COVID

Tue, 26 Jul 2022 22:00:00 +0000

Rachael Evans discusses the needs of people with long COVID and the latest findings from the PHOSP-COVID study.

Read the full article:
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID)

Daniel Munblit and Dale Needham on core outcomes post-COVID-19

Wed, 15 Jun 2022 08:00:00 +0000

Daniel Munblit and Dale Needham discuss the importance of developing a core outcome set for post-COVID-19 condition.

Read the full Position Paper:
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study

Daiana Stolz on antibiotic stewardship in pneumonia

Tue, 24 May 2022 10:00:00 +0000

Daiana Stolz discusses antibiotic stewardship in patients hospitalised with pneumonia and at risk of Gram-negative bacterial infection.

Read the full article:
Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II)

Ablo Wachinou on sleep disordered breathing in Benin

Fri, 08 Apr 2022 22:00:00 +0000

Dr Ablo Wachinou discusses the prevalence of sleep disordered breathing in Benin and how awareness and treatment might be improved.

Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID

Thu, 07 Apr 2022 22:00:00 +0000

Professor Peter Openshaw and Dr Felicity Liew discuss the use of inhaled corticosteroids in the early treatment of COVID and the involvement of the respiratory mucosa in response to viral infection.

Dinh Bui on preterm birth and lung function deficits

Fri, 18 Feb 2022 23:00:00 +0000

Dr Dinh Bui discusses the association between very-to-moderate preterm birth and lung function deficits and COPD at age 53.

Ruvim Izĭckson on a joint flu and COVID-19 vaccine

Mon, 31 Jan 2022 23:00:00 +0000

Ruvim Izĭckson discusses the safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine together with a third dose of the Moderna COVID-19 vaccine in adults aged 65 years and older.

Read the full article:
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 year

Wisia Wedzicha on a vaccine for COPD

Tue, 11 Jan 2022 10:00:00 +0000

Wisia Wedzicha discusses findings of a trial of a vaccine for the prevention of COPD exacerbations and provides her insights for future research.

Read the full article:
Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease

Eileen Rubin on patient-centered ARDS

Thu, 30 Dec 2021 10:00:00 +0000

Eileen Rubin, author of a paper on advancing precision medicine for acute respiratory distress syndrome discusses her delayed diagnosis and how clinician and researcher goals can differ from those of patients.

Read the full article:
Advancing precision medicine for acute respiratory distress syndrome

Daniel Altmann on COVID boosters

Tue, 30 Nov 2021 23:00:00 +0000

Daniel Atlmann discusses the duration of immune protection from COVID vaccination and the crucial implications for the implementation of booster vaccination programmes.

Read the full article:
Waning immunity to SARS-CoV-2: implications for vaccine booster strategies - The Lancet Respiratory Medicine

Michael Kreuter on interstitial lung disease

Mon, 06 Sep 2021 23:00:00 +0000

Comment author Michael Kreuter discusses a series of papers published in The Lancet and The Lancet Respiratory Medicine on interstitial lung disease.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00403-3/fulltext

Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19

Fri, 20 Aug 2021 23:00:00 +0000

Bairbre McNicholas and Jie Li discuss an open label superiority meta-trial looking at the efficacy of awake prone positioning for patients with COVID-19 acute hypoxaemic respiratory failure.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00356-8/fulltext

Charles Sprung and authors on end-of-life practices in ICUs globally

Tue, 03 Aug 2021 23:00:00 +0000

Charles Sprung and fellow co authors Christiane Hartog, Joseph Nates, and Gavin Joynt discuss the Ethicus-II study, which looked at differences in end-of-life care in nearly 200 ICUs across 36 countries.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00261-7/fulltext

Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma

Sat, 10 Jul 2021 23:00:00 +0000

Christopher Brightling discusses the effect of blocking thymic stromal lymphopoietin (TSLP) with tezepelumab in patients with moderate-to-severe uncontrolled asthma.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00226-5/fulltext

Paul Verweij on COVID-19 associated aspergillosis

Wed, 26 May 2021 23:00:00 +0000

Dr. Paul Verweij discusses a Personal View published in TLRM on COVID-19 associated aspergillosis.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00138-7/fulltext

Ignacio Rubio on COVID-19 pathophysiology and phenotypes

Mon, 17 May 2021 23:00:00 +0000

Dr. Ignacio Rubio discusses a comprehensive review of the pathophysiology and phenotypes of COVID-19, the first in a Series of four papers about the pathophysiology of acute disease.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00218-6/fulltext

Kiran Shekar on cytokine adsorption and severe COVID-19 pneumonia

Fri, 14 May 2021 23:00:00 +0000

Dr. Kiran Shekar discusses a randomized controlled trial looking at cytokine adsorption in patients with severe COVID-19 pneumonia.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00207-1/fulltext

Fan Chung on chronic cough and long COVID

Tue, 11 May 2021 15:00:00 +0000

Dr Fan Chung discuses confronting COVID-19-associated cough and the post-COVID syndrome.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00125-9/fulltext

Mepolizumab and the treatment of chronic rhinosinusitis

Fri, 16 Apr 2021 23:00:00 +0000

Dr. Joseph Han discusses the results of the phase III SYNAPSE trial, evaluating the efficacy and safety of mepolizumab in patients with chronic rhinosinusitis.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00097-7/fulltext

Inhaled budesonide in the treatment of early COVID-19

Thu, 15 Apr 2021 13:00:00 +0000

Dr. Mona Bafadhel discusses the STOIC trial, which looked at the use of inhaled budesonide in the treatment of early COVID-19.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00160-0/fulltext

Tocilizumab and COVID-19

Fri, 05 Mar 2021 00:00:00 +0000

Dr. Arvinder Soin discusses the use of tocilizumab plus standard care versus standard care alone in the treatment of moderate to severe COVID-19-associated cytokine release syndrome.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00081-3/fulltext

Interferon treatment and COVID-19

Sat, 06 Feb 2021 00:00:00 +0000

Jordan Feld discusses the use of peginterferon-lambda in the treatment of ambulatory COVID-19 patients.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30566-X/fulltext

Evaluating deterioration in patients with acute COVID-19

Tue, 12 Jan 2021 00:00:00 +0000

Rishi Gupta discusses a model to evaluate and predict the risk of clinical deterioration in patients with acute COVID-19.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30559-2/fulltext

Treatment options in patients with systemic sclerosis-associated interstitial lung disease

Tue, 05 Jan 2021 00:00:00 +0000

Toby Maher discusses the results of the SENSCIS trial, looking at the safety and efficacy of nintedanib in systemic sclerosis-associated interstitial lung disease (SSc-ILD) treated with mycophenolate.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30458-6/fulltext

COVID-19 and severe influenza

Fri, 18 Dec 2020 00:00:00 +0000

Dr. Catherine Quantin discusses a new study looking at the ways severe influenza and COVID-19 are similar and differ.

The second wave and homeless populations

Wed, 11 Nov 2020 16:00:00 +0000

Dan Lewer of University College London discusses a modelling study that looks at housing strategies for homeless populations in the UK during COVID-19.